Matthew F. Plevak

A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar et al. · New England Journal of Medicine · 2002 · 1.5K citations

Medicine, Oncology, Pathology +13

Prevalence of Monoclonal Gammopathy of Undetermined Significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar et al. · New England Journal of Medicine · 2006 · 1.4K citations · Full text

Medicine, Geriatric Medicine, Clinical Epidemiology +2

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Robert A. Kyle, Ellen D. Remstein, Terry M. Therneau et al. · New England Journal of Medicine · 2007 · 919 citations · Full text

Medicine, Hematology, Pathology +17

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau et al. · Blood · 2005 · 697 citations · Full text

Medicine, Pathology, Molecular Pathology +6

Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001

Carol Van Dyke, Matthew F. Plevak, Ross Dierkhising et al. · Clinical Gastroenterology and Hepatology · 2003 · 334 citations

Medicine, Immunology, Internal Medicine +12